¼¼°èÀÇ ¿¬°ñ ¼ºÇü¼ú ½ÃÀå º¸°í¼­(2025³â)
Chondroplasty Global Market Report 2025
»óǰÄÚµå : 1682054
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,160,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,904,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,649,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿¬°ñ ¼ºÇü¼ú ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 5.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 184¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Àç»ýÀÇ·áÀÇ ÅëÇÕ, ¿Ü·¡ ¼ö¼ú¿¡ ´ëÇÑ ÁýÁß, »õ·Î¿î »ýüÀç·áÀÇ µµÀÔ, ±Ù°ñ°Ý°è Áúȯ Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀçȰ ±â¼ú ÅëÇÕ, °üÀý°æ ±â¼ú, ¿¬°ñ º¹±¸ ¹× Àç»ý, ¼ö¼ú ±â±¸ ±â¼ú Çõ½Å, ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ÅëÇÕ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

¿¹»óµÇ´Â °üÀý °ü·Ã ÁúȯÀÇ ±ÞÁõÀº ¿¹Ãø °¡´ÉÇÑ ¹Ì·¡¿¡ ¿¬°ñ ¼ºÇü¼ú ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â Ã˸ÅÁ¦°¡ µÉ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº °üÀýÀÇ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ °Ç°­ ¹®Á¦¸¦ Æ÷ÇÔÇϸç, °úµµÇÑ °üÀý »ç¿ëÀ̳ª »ç°í ¹× ½ºÆ÷Ã÷ °ü·Ã »ç°í¿Í °°Àº °©ÀÛ½º·¯¿î ºÎ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿¬°ñ ¼ºÇü¼úÀº °üÀý ³» ¼Õ»óµÈ ¿¬°ñÀ» Ä¡·áÇÔÀ¸·Î½á ÀÌ·¯ÇÑ °üÀý °ü·Ã ÁúȯÀÇ Ä¡·áÁ¦·Î ÀÛ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ÃÖ±Ù LancetÁö°¡ 2023³â 8¿ù¿¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é ¿µ±¹¿¡¼­ °üÀý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿°Áõ¼º °üÀý¿°ÀÎ ÅëdzÀÇ ¹ßº´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. 2021³â 3¿ù ¼ºÀÎ 1,000¸í´ç 1.40¸í¿¡¼­ 2022³â 3¿ù¿¡´Â 1,000¸í´ç 1.44¸íÀ¸·Î Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ, 2023³â 6¿ù ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)ÀÇ ¿¹Ãø¿¡ µû¸£¸é, 2040³â±îÁö 18¼¼ ÀÌ»ó ¹Ì±¹ ¼ºÀÎ Áß ¾à 7840¸¸ ¸í(25.9%)ÀÌ °üÀý¿° Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ÃßÁ¤µÈ´Ù(BRFSS). µû¶ó¼­ °üÀý °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿¬°ñ ¼ºÇü¼ú ½ÃÀåÀÇ ¼ºÀå ±Ëµµ¿¡ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¹«¸­ °üÀý ¼ö¼ú Áõ°¡´Â ÇâÈÄ ¿¬°ñ ¼ºÇü¼ú ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹«¸­ °üÀý ¼ö¼úÀº ¹«¸­ °üÀýÀ» ´ë»óÀ¸·Î ÇÏ´Â ¿Ü°úÀû °³ÀÔÀ» ÀǹÌÇϸç, ¹«¸­ °üÀýÀÇ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ »óÅÂ, ¼Õ»ó ¹× Àå¾Ö¿¡ ´ëóÇÕ´Ï´Ù. ¿¬°ñ ¼ºÇü¼úÀº °üÀý ³» ¼Õ»óµÈ ¿¬°ñÀÇ ¼öº¹ ¹× ÀçÇü¼º¿¡ ÃÊÁ¡À» ¸ÂÃá ¿Ü°úÀû ½Ã¼ú·Î, ƯÈ÷ ¹«¸­ °ü·Ã Ä¡·á¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ±¹¸³ÀÇÇеµ¼­°ü ÀÚ·á¿¡ µû¸£¸é, 2022³â 1150°³ ÀÌ»óÀÇ ÀÇ·á±â°ü¿¡¼­ ½ÃÇàµÉ °í°üÀý ¹× ¹«¸­°üÀý ¼ö¼ú °Ç¼ö´Â 2020³â ´ëºñ 18.3% ´ëÆø Áõ°¡ÇÏ¿© ÃÑ 240¸¸ °Ç¿¡ ´ÞÇÒ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ, 2023³â 1¿ù °°Àº ÃâóÀÇ ¿¹Ãø¿¡ µû¸£¸é 2040³â±îÁö Àΰø ½½°üÀý Àüġȯ¼ú(TKA)ÀÌ 139% ±ÞÁõÇϰí, 2060³â±îÁö 469% ±ÞÁõÇÒ °ÍÀ̶ó´Â ³î¶ó¿î ¿¹ÃøÀÌ Á¦½ÃµÇ¾ú½À´Ï´Ù. ¹«¸­ °üÀý ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¬°ñ ¼ºÇü¼ú¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÏ¿© ¿¬°ñ ¼ºÇü¼ú ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Chondroplasty is a surgical procedure designed to repair and reshape damaged cartilage within a joint, commonly performed to alleviate pain and improve joint function in cases of cartilage damage caused by conditions such as osteoarthritis or traumatic injuries.

The main types of chondroplasty include radiofrequency ablation chondroplasty, abrasion chondroplasty, patellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty targets minor imperfections in knee cartilage to minimize joint deterioration. Various anatomies, such as knee, shoulder, hip, and others, are addressed using tools such as shavers, radiofrequency devices, and arthroscopes. Chondroplasty procedures are performed in settings such as hospitals, orthopedic clinics, academic research institutions, and others.

The chondroplasty market research report is one of a series of new reports from The Business Research Company that provides chondroplasty market statistics, including chondroplasty industry global market size, regional shares, competitors with a chondroplasty market share, detailed chondroplasty market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. This chondroplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chondroplasty market size has grown strongly in recent years. It will grow from $13.77 billion in 2024 to $14.68 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders.

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $18.43 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems.

The anticipated surge in joint-related disorders stands as a catalyst propelling the expansion of the chondroplasty market in the foreseeable future. These disorders encompass a range of health issues affecting joint functionality, often stemming from excessive joint use or abrupt injuries, such as accidents or sports-related incidents. Chondroplasty serves as a treatment for these joint-related disorders by addressing damaged cartilage within a joint. Recent data published by The Lancet in August 2023 highlighted a rise in the incidence of gout, an inflammatory arthritis impacting joints, in the UK. The diagnoses increased from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. Furthermore, projections from the Centers for Disease Control and Prevention (CDC) in June 2023 estimate that by 2040, approximately 78.4 million (25.9%) US adults aged 18 years or older may receive doctor-diagnosed arthritis (BRFSS). Hence, the escalating prevalence of joint-related disorders is a driving force behind the chondroplasty market's growth trajectory.

The upswing in knee surgeries is poised to fuel the advancement of the chondroplasty market in the forthcoming period. Knee surgery denotes a surgical intervention targeting the knee joint to address a spectrum of conditions, injuries, or disorders impacting knee functionality. Chondroplasty, a surgical procedure focused on repairing and reshaping damaged cartilage within a joint, finds particular application in knee-related treatments. Notably, data from the National Library of Medicine revealed a substantial 18.3% increase in total hip and knee operations performed at over 1150 facilities in 2022 compared to 2020, totaling 2.4 million procedures. Moreover, projections from the same source in January 2023 indicate a projected surge of 139% in total knee arthroplasty (TKA) by 2040 and a striking 469% surge by 2060. As knee surgeries increase, the demand for chondroplasty is correspondingly boosted, fostering the growth dynamics of the chondroplasty market.

Leading companies in the chondroplasty market are advancing the development of autologous chondrocyte-based therapies to improve cartilage repair by leveraging patients' own cells, thereby minimizing immune rejection and encouraging natural regeneration. Autologous chondrocytes, which are cartilage cells harvested from a patient's body (typically from a non-weight-bearing area of the joint), provide a personalized approach to treatment. For example, in August 2024, Vericel Corporation, a U.S.-based biopharmaceutical company, gained FDA approval for its MACI Arthro (Matrix Autologous Chondrocyte Implantation), now commercially available. This innovation in knee cartilage defect treatment allows orthopedic surgeons to conduct the procedure through minimally invasive incisions using specialized instruments, offering a less invasive alternative to traditional methods. This approach is anticipated to improve patient recovery and reduce post-operative complications.

In July 2023, Avanos Medical Inc., a prominent US-based company specializing in pain management and chronic care solutions, successfully completed the acquisition of Diros Technology Inc. for a sum totaling $60 million. This strategic acquisition serves to bolster Avanos' standing as a frontrunner in the realm of radiofrequency (RF) technology, expanding its portfolio with a comprehensive range of cutting-edge pain treatment devices. Diros Technology Inc., based in Canada, specializes in crafting radiofrequency devices tailored to address joint disorders such as knee, cervical, and lumbar pain. This acquisition marks a significant step for Avanos, enriching its offerings and solidifying its position within the industry by integrating Diros' expertise and unique devices into its product line.

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

North America was the largest region in the chondroplasty market in 2024. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chondroplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chondroplasty Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chondroplasty ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chondroplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chondroplasty Market Characteristics

3. Chondroplasty Market Trends And Strategies

4. Chondroplasty Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chondroplasty Growth Analysis And Strategic Analysis Framework

6. Chondroplasty Market Segmentation

7. Chondroplasty Market Regional And Country Analysis

8. Asia-Pacific Chondroplasty Market

9. China Chondroplasty Market

10. India Chondroplasty Market

11. Japan Chondroplasty Market

12. Australia Chondroplasty Market

13. Indonesia Chondroplasty Market

14. South Korea Chondroplasty Market

15. Western Europe Chondroplasty Market

16. UK Chondroplasty Market

17. Germany Chondroplasty Market

18. France Chondroplasty Market

19. Italy Chondroplasty Market

20. Spain Chondroplasty Market

21. Eastern Europe Chondroplasty Market

22. Russia Chondroplasty Market

23. North America Chondroplasty Market

24. USA Chondroplasty Market

25. Canada Chondroplasty Market

26. South America Chondroplasty Market

27. Brazil Chondroplasty Market

28. Middle East Chondroplasty Market

29. Africa Chondroplasty Market

30. Chondroplasty Market Competitive Landscape And Company Profiles

31. Chondroplasty Market Other Major And Innovative Companies

32. Global Chondroplasty Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chondroplasty Market

34. Recent Developments In The Chondroplasty Market

35. Chondroplasty Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â